• Je něco špatně v tomto záznamu ?

Determinants of occurrence and survival after sudden cardiac arrest-A European perspective: The ESCAPE-NET project

JP. Empana, MT. Blom, BW. Bӧttiger, N. Dagres, JM. Dekker, G. Gislason, X. Jouven, T. Meitinger, G. Ristagno, PJ. Schwartz, M. Jonsson, J. Tfelt-Hansen, A. Truhlar, HL. Tan, . ,

. 2018 ; 124 (-) : 7-13. [pub] 20171212

Jazyk angličtina Země Irsko

Typ dokumentu časopisecké články, pozorovací studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19001034

AIMS: The ESCAPE-NET project ("European Sudden Cardiac Arrest network- towards Prevention, Education and New Effective Treatments") aims to study: (1) risk factors and mechanisms for the occurrence of sudden cardiac arrest (SCA) in the population, and (2) risk factors and treatment strategies for survival after SCA on a European scale. METHODS: This is an Horizon2020 funded program of the European Union, performed by a European public-private consortium of 16 partners across 10 EU countries. There are 11 deep-phenotyped SCA cohorts for the study of risk factors and treatment strategies for survival after SCA, and 5 deep-phenotyped observational prospective population cohorts for the study of risk factors for occurrence of SCA. Personalized risk scores for predicting SCA onset and for predicting survival after SCA will be derived and validated. RESULTS: The 11 clinical studies with SCA cases comprise 85,790 SCA cases; the 5 observational prospective population cohorts include 53,060 subjects. A total of 15,000 SCA samples will be genotyped for common and rare variants at the Helmholtz Zentrum München (Germany) using the Illumina Global Screening Array which contains > 770,000 SNPs, and after imputation, a database of an estimated > 9 million variants will be available for genome wide association studies. Standardization of risk factors definition and outcomes is ongoing. An Executive Committee has been created along with a Collaboration Policy document. CONCLUSION: ESCAPE-NET will complement ongoing efforts on SCA outside Europe and within Europe including the EuReCa project.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19001034
003      
CZ-PrNML
005      
20190115120923.0
007      
ta
008      
190107s2018 ie f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.resuscitation.2017.12.011 $2 doi
035    __
$a (PubMed)29246744
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ie
100    1_
$a Empana, Jean-Philippe $u Université Paris Descartes, INSERM UMRS-970, Paris Cardiovascular Research Centre, Paris, France.
245    10
$a Determinants of occurrence and survival after sudden cardiac arrest-A European perspective: The ESCAPE-NET project / $c JP. Empana, MT. Blom, BW. Bӧttiger, N. Dagres, JM. Dekker, G. Gislason, X. Jouven, T. Meitinger, G. Ristagno, PJ. Schwartz, M. Jonsson, J. Tfelt-Hansen, A. Truhlar, HL. Tan, . ,
520    9_
$a AIMS: The ESCAPE-NET project ("European Sudden Cardiac Arrest network- towards Prevention, Education and New Effective Treatments") aims to study: (1) risk factors and mechanisms for the occurrence of sudden cardiac arrest (SCA) in the population, and (2) risk factors and treatment strategies for survival after SCA on a European scale. METHODS: This is an Horizon2020 funded program of the European Union, performed by a European public-private consortium of 16 partners across 10 EU countries. There are 11 deep-phenotyped SCA cohorts for the study of risk factors and treatment strategies for survival after SCA, and 5 deep-phenotyped observational prospective population cohorts for the study of risk factors for occurrence of SCA. Personalized risk scores for predicting SCA onset and for predicting survival after SCA will be derived and validated. RESULTS: The 11 clinical studies with SCA cases comprise 85,790 SCA cases; the 5 observational prospective population cohorts include 53,060 subjects. A total of 15,000 SCA samples will be genotyped for common and rare variants at the Helmholtz Zentrum München (Germany) using the Illumina Global Screening Array which contains > 770,000 SNPs, and after imputation, a database of an estimated > 9 million variants will be available for genome wide association studies. Standardization of risk factors definition and outcomes is ongoing. An Executive Committee has been created along with a Collaboration Policy document. CONCLUSION: ESCAPE-NET will complement ongoing efforts on SCA outside Europe and within Europe including the EuReCa project.
650    _2
$a kohortové studie $7 D015331
650    _2
$a komorbidita $7 D015897
650    _2
$a databáze faktografické $7 D016208
650    _2
$a náhlá srdeční smrt $x epidemiologie $7 D016757
650    _2
$a urgentní zdravotnické služby $x statistika a číselné údaje $7 D004632
650    _2
$a lidé $7 D006801
650    _2
$a zástava srdce mimo nemocnici $x etiologie $x mortalita $7 D058687
650    _2
$a surveillance populace $x metody $7 D011159
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a rizikové faktory $7 D012307
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Blom, Marieke T $u Department of Cardiology, Heart Center, Academic Medical Center, Amsterdam, The Netherlands.
700    1_
$a Bӧttiger, Bernd W $u European Resuscitation Council, Brussels, Belgium; Department of Anesthesiology and Intensive Care Medicine, University Hospital of Cologne, Cologne, Germany.
700    1_
$a Dagres, Nikolaos $u European Heart Rhythm Association, representing the European Society of Cardiology, Sophia Antipolis, France.
700    1_
$a Dekker, Jacqueline M $u VU University Medical Center, Amsterdam, The Netherlands.
700    1_
$a Gislason, Gunnar $u Department of Cardiology, Copenhagen University Hospital, Gentofte, Denmark and Danish Heart Foundation.
700    1_
$a Jouven, Xavier $u Université Paris Descartes, INSERM UMRS-970, Paris Cardiovascular Research Centre, Paris, France.
700    1_
$a Meitinger, Thomas $u Department of Human Genetics, Helmholtz Center, Munich, Germany.
700    1_
$a Ristagno, Giuseppe $u IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy; Italian Resuscitation Council, Bologna, Italy.
700    1_
$a Schwartz, Peter J $u IRCCS Istituto Auxologico Italiano, Reference Network for Rare and Low Prevalence Complexe Diseases of the Heart (ERN GUARD-HEART), Italy.
700    1_
$a Jonsson, Martin $u Center for Resuscitation Science, Department of Medicine, Solna, Karolinska Institute, Stockholm, Sweden.
700    1_
$a Tfelt-Hansen, Jacob $u The Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark and Department of Forensic Medicine, Faculty of Medical Sciences, University of Copenhagen, Denmark and Reference Network for Rare and Low Prevalence Complexe Diseases of the Heart (ERN GUARD-HEART).
700    1_
$a Truhlar, Anatolij $u Emergency Medical Services of the Hradec Kralove Region, Czech Republic.
700    1_
$a Tan, Hanno L $u Department of Cardiology, Heart Center, Academic Medical Center, Amsterdam, The Netherlands. Electronic address: h.l.tan@amc.nl.
700    1_
$a ,
773    0_
$w MED00004106 $t Resuscitation $x 1873-1570 $g Roč. 124, č. - (2018), s. 7-13
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29246744 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20190115121134 $b ABA008
999    __
$a ok $b bmc $g 1364983 $s 1039157
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 124 $c - $d 7-13 $e 20171212 $i 1873-1570 $m Resuscitation $n Resuscitation $x MED00004106
LZP    __
$a Pubmed-20190107

Najít záznam

Citační ukazatele

Možnosti archivace